Inhibition of KV and KCa channels antagonizes NO-induced relaxation in pulmonary artery

American Journal of Physiology

Volumn 272, Issue 2 PART 2, 1997, Pages

  Wang, Jian ^a   Rubin, Lewis J ^a   Yuan, Xiao Jian ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

4 aminopyridine; Calcium activated potassium channels; Charybdotoxin; Glibenclamide; Guanosine 3 ,5 cyclic monophosphate; Nitric oxide; Nitroprusside; Voltage gated potassium channels

Indexed keywords

EID: 0030901661     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Archer, S. L., J. M. C. Hang, V. Hampl, D. P. Nelson, P. J. Shultz, and E. K. Weir. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Nail. Acad. Sei. USA 91: 7583-7587, 1994.
2. Arnold, W. P., C. K. Mittal, S. Katsuki, and F. Murad. Nitric oxide activates guanylate cyclase and increases guanosine 3',5'cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sei. USA 74: 3203-3207, 1977.
3. Bialecki, R. A., and C. Stinson-Fisher. Kca channel antagonists reduce NO donor-mediated relaxation of vascular and trachéal smooth muscle. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L152-L159, 1995.
4. Blatter, L. A., and W. G. Wier. Nitric oxide decreases [Ça2], in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 15: 122-131, 1995.
5. Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature Land. 368: 850-853,1994.
6. Clapp, L. H., and A. M. Gurney. Modulation of calcium movements by nitroprusside in isolated vascular smooth muscle cells. Pfluegers Arch. 418: 462-470,1991.
7. Clapp, L. H., and A. M. Gurney. ATP-sensitive Kchannels regulate resting potential of pulmonary arterial smooth muscle cells. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H916-H920, 1992.
8. Folders, F. F., Y. Ohta, Y. Shiwaku, E. S. Vizi, J. J. Van Dijk, and K. Morita. The influence of 4-aminopyridine on parasympathetic transmission. In: Aminopyridin.es and Similarly Acting Drugs: Effects on Nerves, Muscles and Synapses, edited by P. Léchât, S. Thesleff, and W. C. Bowman. Oxford, UK: Pergamon, 1982, p. 127-139.
9. Furchgott, R. F. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 24: 175-197,1984.
10. Gambone, L. M., and P. A. Murray. Sodium nitroprussideinduced pulmonary vasodilation is selectively attenuated by ATP-sensitive K+-channel inhibition in conscious dogs (Abstract). FASEB J. 8: A25,1994.
11. Giaid, A., and D. Saleh. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. AT. Engl. J. Med. 333: 214-221,1995.
12. Gruetter, C. A., D. Y. Gruetter, J. E. Lyon, P. J. Kadowitz, and L. J. Ignarro. Relationship between cyclic guanosine 3',5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite, and nitric oxide: effects of méthylène blue and hemoglobin. J. Pharmacol. Exp. Ther. 219: 181-186, 1981.
13. Hevel, J. M., and M. A. Marietta. Nitric-oxide synthase assays. Methods Enzymol. 233: 250-258,1994.
14. Ignarro, L. J., T. M. Burke, K. S. Wood, M. S. Wolin, and P. J. Kadowitz. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J. Pharmacol. Exp. Ther. 228: 682-690, 1984.
15. Ignarro, L. J., R. E. Byrns, G. M. Buga, and K. S. Wood. Endothelium derived relaxing factor from pulmonary artery and vein possesses pharmacologie and chemical properties identical to those of nitric oxide radical. Circ. Res. 61: 866-879,1987.
16. Janigro, D., G. A. West, T.-S. Nguyen, and H. R. Winn. Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ. Res. 75: 528-538, 1994.
17. Khan, S. A., R. Mathews, and K. D. Meisheri. Role of calcium-activated K+ channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide. J. Pharmacol. Exp. Ther. 267: 1327-1335,1993.
18. Kinsella, J. P., S. R. Neish, E. Shaffer, and S. Abman. Low dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819-820,1992.
19. Koh, S. D., J. D. Campbell, A. Carl, and K. M. Sanders. Nitric oxide activates multiple potassium channels in canine colonie smooth muscle. J. Physiol. Land. 489: 735-743,1995.
20. Lipton, S. A., Y.-B. Choi, Z.-H. Pan, S. Z. Lei, H.-S. V. Chen, J. N. Sucher, J. Loscalzo, D. J. Singel, and J. S. Stamler. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrosocompounds. Nature Land. 364: 626-632, 1993.
21. Lu, M., and W.-H. Wang. Nitric oxide regulates the lowconductance K+ channel in basolateral membrane of cortical collecting duct. Am. J. Physiol. 270 (Cell Physiol. 39): C1336C1342,1996.
22. McDonald, T. F., S. Pelzer, W. Trautwein, and D. J. Pelzer. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. PhysioL Rev. 74: 365-507, 1994.
23. Mulsch, A., R. Busse, S. Liebau, and U. Forstermann. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmacol. Exp. Ther. 247: 283-288, 1988.
24. Nelson, M. T., J. B. Patlak, J. F. Worley, and N. B. Standen. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am. J. PhysioL 259 (Cell PhysioL 28): C3-C18, 1990.
25. Nelson, M. T., and J. M. Quayle. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. PhysioL 268 (Cell PhysioL 37): C799-C822,1995.
26. Palmer, R. M. J., D. S. Ashton, and S. Moncada. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature Land. 333: 664-666,1988.
27. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature Land. 327: 524-526, 1987.
28. Pepke-Zaba, J., T. W. Higenbottam, A. T. Dinh-Xuan, D. Stone, and J. Wallwork. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338: 1173-1174,1991.
29. Roberts, J. D., Jr., D. M. Polaner, P. Lang, and W. M. Zapol. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818-819,1992.
30. Robertson, B. E., R. Schubert, J. Hescheler, and M. T. Nelson. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am. J. PhysioL 265 (Cell PhysioL 34): C299-C303,1993.
31. Schmidt, M. J., B. D. Sawyer, L. L. Truex, W. S. Marshall, and J. H. Fleisch. LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate. J. Pharmacol. Exp. Ther. 232: 764-769, 1985.
32. Stamler, J. S., E. Loh, M.-A. Roddy, K. E. Currie, and M. A. Creager. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 20352040,1994.
33. Tsuura, Y., H. Ishida, S. Hayashi, K. Sakamoto, M. Horie, and Y. Seino. Nitric oxide opens ATP-sensitive K+ channels through suppression of phosphofructokinase activity and inhibits glucose-induced insulin release in pancreatic ßcells. J. Gen. PhysioL 104: 1079-1098,1994.
34. Wolin, M. S., K. S. Wood, and L. J. Ignarro. Guanylate cyclase from bovine lung: a kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme and nitrosylheme. J. Biol. Chem. 257: 13312-13320, 1982.
35. Yuan, X.-J. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]; in pulmonary arterial myocytes. Circ. Res. 77: 370-378, 1995.
36. Yuan, X.-J., M. L. Tod, L. J. Rubin, and M. P. Blaustein. Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am. J. PhysioL 259 (Heart Circ. PhysioL 28): H281-H289,1990.
37. Yuan, X.-J., M. L. Tod, L. J. Rubin, and M. P. Blaustein. NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltagegated K1 channels. Proc. Natl. Acad. Sei. USA. 93:10489-10494, 1996.
38. Zapol, W. M., S. Rimar, N. Gillis, M. Marietta, and C. W. Bosken. Nitric oxide and the lung. Am. J. Respir. Crû. Care Med. 149: 1375-1380,1994.